Jasbir Seehra
Chief Executive Officer at Keros Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Keros Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Keros Therapeutics Inc. May 30, 202499.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 2, 2026 | Keros Therapeutics Inc. | Option exercise | +55,000 | $0.30 | $16,500 |
| Feb 19, 2026 | Keros Therapeutics Inc. | Open-market sale | −7,015 | $16.17 | $113,433 |
| Sep 3, 2025 | Keros Therapeutics Inc. | Grant or award | +90,500 | — | — |
| Apr 4, 2025 | Keros Therapeutics Inc. | Option exercise | +49,367 | $0.30 | $14,810 |
| Apr 8, 2023 | Keros Therapeutics Inc. | Option exercise | +4,000 | $0.48 | $1,920 |
Questions about Jasbir Seehra
What boards is Jasbir Seehra on?
Jasbir Seehra sits on the board of Keros Therapeutics Inc.
What company is Jasbir Seehra the CEO of?
Jasbir Seehra is Chief Executive Officer of Keros Therapeutics Inc.
How long has Jasbir Seehra served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.